# Alona Muzikansky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alona-muzikansky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,704 |
| Field | Glioma Diagnosis and Treatment |
| h-index | 91 |
| i10-index | 221 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5013091949 |
| ORCID iD | 0000-0001-7585-8181 |
| Works | 501 |

## Researcher papers

Showing 12 of 18.

- [Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer](https://scholariq.org/papers/early-palliative-care-for-patients-with-metastatic-non-small-cell-lung-cancer/)
- [Isolation of rare circulating tumour cells in cancer patients by microchip technology](https://scholariq.org/papers/isolation-of-rare-circulating-tumour-cells-in-cancer-patients-by-microchip/)
- [Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells](https://scholariq.org/papers/detection-of-mutations-in-i-egfr-i-in-circulating-lung-cancer-cells/)
- [Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial](https://scholariq.org/papers/effects-of-early-integrated-palliative-care-in-patients-with-lung-and-gi-cancer/)
- [First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations](https://scholariq.org/papers/first-line-gefitinib-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [Bevacizumab for recurrent malignant gliomas](https://scholariq.org/papers/bevacizumab-for-recurrent-malignant-gliomas/)
- [Effect of Early Palliative Care on Chemotherapy Use and End-of-Life Care in Patients With Metastatic Non–Small-Cell Lung Cancer](https://scholariq.org/papers/effect-of-early-palliative-care-on-chemotherapy-use-and-end-of-life-care-in/)
- [Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma](https://scholariq.org/papers/perioperative-ca19-9-levels-can-predict-stage-and-survival-in-patients-with/)
- [Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors](https://scholariq.org/papers/phase-ii-study-of-temozolomide-and-thalidomide-in-patients-with-metastatic/)
- [<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes](https://scholariq.org/papers/i-egfr-i-mutant-adenocarcinomas-that-transform-to-small-cell-lung-cancer-and/)
- [Heterogeneity Underlies the Emergence of <i>EGFR</i> T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor](https://scholariq.org/papers/heterogeneity-underlies-the-emergence-of-i-egfr-i-t790-wild-type-clones/)
- [The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human Gliomas](https://scholariq.org/papers/the-prognostic-significance-of-phosphatidylinositol-3-kinase-pathway-activation/)

## Researcher topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.